New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 11, 2014
07:08 EDTAZN, NKTRNektar stock trading halted today
Nektar Therapeutics (NKTR) announced that NASDAQ has halted trading of the company's common stock. The FDA's Anesthetic and Analgesic Drug Products Advisory Committee is meeting on June 11-12 to discuss potential cardiovascular risk associated with peripherally-acting opioid receptor antagonists which includes MOVANTIK, an investigational treatment for opioid-induced constipation being developed by Nektar partner AstraZeneca (AZN).
News For NKTR;AZN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
August 27, 2015
07:51 EDTAZNRoche catching up fast to Bristol-Myers in immuno-oncology, says Jefferies
Subscribe for More Information
August 24, 2015
05:13 EDTAZNAstraZeneca to collaborate with Peregrine on cancer immunotherapy clinical trial
Subscribe for More Information
August 23, 2015
12:35 EDTAZNBiotech firms could see 'billions' in sales from new cancer drugs, Barron's says
Subscribe for More Information
August 20, 2015
11:33 EDTAZNLeerink major pharmaceuticals analyst holds an analyst/industry conference call
Subscribe for More Information
09:23 EDTAZNAdvaxis, MedImmune begin enrollment in axalimogene filolisbac Phase I/II study
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use